EAF2 and hepatocellular carcinoma: Consistent with its potential tumor suppressive role in the human, Eaf2/U19-knockout mice develop lung adenocarcinoma, hepatocellular carcinoma, B-cell lymphoma, and high-grade prostate intraepithelial neoplasia [10].